SYNDAX PHARMACEUTICALS INC (SNDX) Stock Analyst Earnings Estimates
NASDAQ:SNDX - Nasdaq - US87164F1057 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.5M | 1.5M | 139.7M 9,213.33% | 339.997K -100.00% | 98.298M | 92.199M -6.20% | 201.26M 118.29% | 408.25M 102.85% | 571.55M 40.00% | 662.18M 15.86% | 870.49M 31.46% | 1.168B 34.18% | 1.2B 2.74% | ||
| EBITDA YoY % growth | -57.41M 24.28% | -71.31M -24.21% | 26.24M 136.80% | -152.514M -678.39% | -237.536M -51.51% | -190.54M 17.14% | -336.336M -76.52% | -215.272M 36.00% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -57.5M 24.24% | -71.4M -24.17% | 26.2M 136.69% | -152.792M -679.39% | -230.441M -51.48% | -280.234M -21.87% | -372.855M -33.05% | -277.93M 25.46% | -141.498M 49.09% | 13.668M 109.66% | 118.32M 765.67% | 264.45M 123.50% | 415.75M 57.21% | 423.25M 1.80% | |
| Operating Margin | -3,833.33% | -4,760.00% | 18.75% | -44,939.40% | N/A | -285.09% | -404.40% | -138.10% | -34.66% | 2.39% | 17.87% | 30.38% | 35.60% | 35.27% | |
| EPS YoY % growth | -1.85 36.43% | -1.88 -1.62% | 0.43 122.87% | -2.58 -669.77% | -3.02 -20.82% | -3.25 -9.66% | -3.98 -22.63% | -3.09 22.44% | -1.58 48.96% | 0.07 104.66% | 1.13 1,436.11% | 2.52 122.97% | 3.85 52.88% | 3.80 -1.19% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.25 75.06% | -1.04 -22.42% | -1.03 -28.84% | -1.03 -4.90% | -0.88 -253.39% |
| Revenue Q2Q % growth | 87.442M | 13.766M | 19.04M 444.00% | 27.178M 117.42% | 47.095M -46.14% |
| EBITDA Q2Q % growth | 15M 119.26% | -78.188M 1.66% | -78.265M -5.46% | -76.061M 15.08% | -25.643M -270.95% |
| EBIT Q2Q % growth | -32.03M 58.89% | -97.272M -22.33% | -96.524M -30.06% | -93.612M -4.50% | -80.046M -149.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.98 -34.25% | -1.14 | 0.16 | 13.67% |
| Q2 2024 Q2Q % growth | -0.80 -25.00% | -0.93 | 0.13 | 14.20% |
| Q1 2024 Q2Q % growth | -0.85 -44.07% | -1.00 | 0.15 | 14.84% |
| Q4 2023 Q2Q % growth | -1.00 -61.29% | -1.01 | 0.01 | 1.39% |
| Q3 2023 Q2Q % growth | -0.73 -25.86% | -0.81 | 0.08 | 10.03% |
| Q2 2023 Q2Q % growth | -0.64 -3.23% | -0.75 | 0.11 | 14.31% |
| Q1 2023 Q2Q % growth | -0.59 6.35% | -0.61 | 0.02 | 2.90% |
| Q4 2022 Q2Q % growth | -0.62 -134.25% | -0.66 | 0.04 | 6.31% |
| Q3 2022 Q2Q % growth | -0.58 -45.00% | -0.65 | 0.07 | 10.45% |
| Q2 2022 Q2Q % growth | -0.62 -40.91% | -0.65 | 0.03 | 4.53% |
| Q1 2022 Q2Q % growth | -0.63 -16.67% | -0.65 | 0.02 | 2.73% |
| Q4 2021 Q2Q % growth | 1.81 511.36% | 0.28 | 1.53 | 537.56% |
| Q3 2021 Q2Q % growth | -0.40 13.04% | -0.24 | -0.16 | -69.27% |
| Q2 2021 Q2Q % growth | -0.44 -4.76% | -0.73 | 0.29 | 39.67% |
| Q1 2021 Q2Q % growth | -0.54 3.57% | -0.66 | 0.12 | 18.34% |
| Q4 2020 Q2Q % growth | -0.44 | -0.50 | 0.06 | 11.33% |
| Q3 2020 Q2Q % growth | -0.46 -12.20% | -0.45 | -0.01 | -3.12% |
| Q2 2020 Q2Q % growth | -0.42 10.64% | -0.45 | 0.03 | 7.64% |
| Q1 2020 Q2Q % growth | -0.56 -5.66% | -0.52 | -0.04 | -6.99% |
| Q4 2019 Q2Q % growth | -0.44 | -0.43 | -0.01 | -1.43% |
| Q3 2019 Q2Q % growth | -0.41 | -0.48 | 0.07 | 14.61% |
| Q2 2019 Q2Q % growth | -0.47 | -0.44 | -0.03 | -7.53% |
| Q1 2019 Q2Q % growth | -0.53 | -0.57 | 0.04 | 6.40% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 12.5M | 11.423M | 1.077M | 9.43% |
| Q1 2023 Q2Q % growth | 437.141K | -437.141K | -100.00% | |
| Q4 2022 Q2Q % growth | -100.00% | 382.5K | -382.5K | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | 1.403M | -1.403M | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 2.173M | -2.173M | -100.00% |
| Q4 2021 Q2Q % growth | 126.6M 31,550.00% | 59.854M | 66.746M | 111.51% |
| Q3 2021 Q2Q % growth | 12.4M 3,000.00% | 29.937M | -17.537M | -58.58% |
| Q2 2021 Q2Q % growth | 400K | 183.6K | 216.4K | 117.86% |
| Q1 2021 Q2Q % growth | 400K | 229.5K | 170.5K | 74.29% |
| Q4 2020 Q2Q % growth | 400K | 204K | 196K | 96.08% |
| Q3 2020 Q2Q % growth | 400K | 306K | 94K | 30.72% |
| Q2 2020 Q2Q % growth | 400K | 408K | -8K | -1.96% |
| Q1 2020 Q2Q % growth | 400K | 860.033K | -460.033K | -53.49% |
| Q4 2019 Q2Q % growth | 400K | 379.032K | 20.968K | 5.53% |
| Q3 2019 Q2Q % growth | 400K | 379.032K | 20.968K | 5.53% |
| Q2 2019 Q2Q % growth | 400K | 383.857K | 16.143K | 4.21% |
| Q1 2019 Q2Q % growth | 400K | 371.79K | 28.21K | 7.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -4080.17% | -4080.17% | -12.22% | 13.85% |
| Revenue | -25.24% | -31.22% | -0.53% | 177.24% |